Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

574
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
574
Cholinergic Antagonists: Therapeutic Uses01:26

Cholinergic Antagonists: Therapeutic Uses

749
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:    
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
749
Cholinergic Antagonists: Pharmacokinetics01:24

Cholinergic Antagonists: Pharmacokinetics

441
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations,  while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
441
Cranial and Spinal Meninges01:19

Cranial and Spinal Meninges

1.4K
The cranial and spinal meninges are complex protective structures surrounding the central nervous system (CNS), consisting of the brain and spinal cord. These meninges consist of the dura mater, the arachnoid mater, and the pia mater. They protect the CNS, provide structural support, and aid in circulating cerebrospinal fluid (CSF).
Cranial Meninges
These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...
1.4K
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

237
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
237
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Migraine and Cardiovascular Risk: A Scoping Review of Vascular Outcomes, Risk Assessment, and Endothelial Dysfunction.

Life (Basel, Switzerland)·2026
Same author

CGRP-Targeting Therapies in Vestibular Migraine: A Synthesis of Observational Evidence with Direction-of-Effect Analysis.

Medical sciences (Basel, Switzerland)·2026
Same author

Preliminary Psychometric Evaluation of the Romanian Version of the Hospital Anxiety and Depression Scale in Relapsing-Remitting Multiple Sclerosis.

Journal of clinical medicine·2026
Same author

New Directions in Migraine Pathophysiology: The Glymphatic System and PACAP.

Life (Basel, Switzerland)·2026
Same author

Alpha-Lipoic Acid and Benfotiamine in Diabetic Peripheral Neuropathy: A Critical Review of Mechanistic Rationale and Clinical Evidence Within a Nutritional Therapeutic Framework.

Nutrients·2026
Same author

MicroRNA profiles in multiple sclerosis: A review of the literature.

Journal of neuroimmunology·2026

Related Experiment Video

Updated: Jul 5, 2025

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

18.3K

Migraine Comorbidities.

Dan Iulian Cuciureanu1,2, Cătălina Elena Bistriceanu1,3, Georgiana-Anca Vulpoi2

  • 1Neurology Department, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.

Life (Basel, Switzerland)
|January 23, 2024
PubMed
Summary

Migraine often co-occurs with conditions like epilepsy and mood disorders due to shared mechanisms. Understanding these links, including the gut microbiome

Keywords:
CGRPanxiety and mood disorderscomorbiditiesepilepsygut–brain axismicrobiomemigraine

More Related Videos

Author Spotlight: Deciphering Electrical Networks Behind Complex Brain Activities and Disorders
05:49

Author Spotlight: Deciphering Electrical Networks Behind Complex Brain Activities and Disorders

Published on: November 1, 2024

806
Investigating Migraine-Like Behavior Using Light Aversion in Mice
05:23

Investigating Migraine-Like Behavior Using Light Aversion in Mice

Published on: August 11, 2021

3.8K

Related Experiment Videos

Last Updated: Jul 5, 2025

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

18.3K
Author Spotlight: Deciphering Electrical Networks Behind Complex Brain Activities and Disorders
05:49

Author Spotlight: Deciphering Electrical Networks Behind Complex Brain Activities and Disorders

Published on: November 1, 2024

806
Investigating Migraine-Like Behavior Using Light Aversion in Mice
05:23

Investigating Migraine-Like Behavior Using Light Aversion in Mice

Published on: August 11, 2021

3.8K

Area of Science:

  • Neuroscience
  • Gastroenterology
  • Psychiatry

Background:

  • Recent decades have revealed interrelationships between migraine and comorbidities like epilepsy, mood disorders, and irritable bowel syndrome.
  • These conditions share common pathophysiological mechanisms, including ion channel dysfunction and altered neurotransmission.
  • Migraine comorbidities influence clinical course, treatment response, and outcomes.

Purpose of the Study:

  • To explore the bench-to-bedside connections between migraine and its comorbid conditions.
  • To highlight shared pathophysiological mechanisms underlying migraine and associated disorders.
  • To suggest how understanding these links can inform future treatment strategies.

Main Methods:

  • Review of recent neuroscience, psychiatric, and gastroenterological research.
  • Analysis of molecular, genetic, and physiological links between migraine and comorbidities.
  • Exploration of the gut-brain axis and microbiome's role in migraine.

Main Results:

  • Epilepsy and migraine share ion channel and glutamatergic transmission dysfunctions.
  • Mood disorders, particularly major depressive disorder, are significant psychiatric comorbidities with a genetic basis.
  • The gut microbiome and gut-brain axis are implicated in migraine pathophysiology, with links to irritable bowel syndrome.

Conclusions:

  • Migraine comorbidities like epilepsy, mood disorders, and gut issues share underlying mechanisms.
  • These shared pathways offer insights into treatment strategies for migraine and its associated conditions.
  • Further research into these connections can significantly impact clinical treatment choices.